Required fields are marked with *

Verification code

PF-232798

{PARAM:[Name]}()
Category Human immunodeficiency Virus (HIV)
CAS 849753-15-7
Description PF-232798 is a second-generation oral CCR5 antagonist. It has broad-spectrum anti-HIV-1 activity.
Quotation Now

Product Information

Synonyms PF-232798;849753-15-7;UNII-63P7W7886U;PF 232798;PF-00232798;N-((S)-1-(3-Fluorophenyl)-3-((1R,3S,5S)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]octan-8-yl)propyl)acetamide;CHEMBL1649931;63P7W7886U;N-[(1S)-1-(3-fluorophenyl)-3-[(1R,5S)-3-[2-methyl-5-(2-methylpropanoyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridin-1-yl]-8-azabicyclo[3.2.1]octan-8-yl]propyl]acetamide;PF232798;PF 00232798;SCHEMBL1049072;DTXSID40234029;GLXC-15759;BDBM50334964;AKOS027338694;DB14813;DA-76783;HY-14388;N-(1-(3-fluorophenyl)-3-((3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo(4,5-c)pyridin-1-yl)-8-azabicyclo(3.2.1)oct-8-yl)propyl)acetamide;CS-0003331;Q27263634;1004533-10-1;ACETAMIDE, N-((1S)-1-(3-FLUOROPHENYL)-3-((3-ENDO)-3-(4,5,6,7-TETRAHYDRO-2-METHYL-5-(2-METHYL-1-OXOPROPYL)-1H-IMIDAZO(4,5-C)PYRIDIN-1-YL)-8-AZABICYCLO(3.2.1)OCT-8-YL)PROPYL)-;n-{(1S)-3-[3-endo-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-(3-fluorophenyl)propyl}acetamide;
IUPAC Name N-[(1S)-1-(3-fluorophenyl)-3-[(1R,5S)-3-[2-methyl-5-(2-methylpropanoyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridin-1-yl]-8-azabicyclo[3.2.1]octan-8-yl]propyl]acetamide
Molecular Weight 349.13
Molecular Formula C15H9BrO5
Canonical SMILES C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C(=C3O2)Br)O)O)O
InChI InChI=1S/C29H40FN5O2/c1-18(2)29(37)33-12-11-28-27(17-33)31-19(3)35(28)25-15-23-8-9-24(16-25)34(23)13-10-26(32-20(4)36)21-6-5-7-22(30)14-21/h5-7,14,18,23-26H,8-13,15-17H2,1-4H3,(H,32,36)/t23-,24+,25?,26-/m0/s1
InChIKey QETUKYDWZIRTEI-HLMSNRGBSA-N
Boiling Point 765.2±60.0 °C at 760 mmHg
Purity 98%
Density 1.3±0.1 g/cm3
Solubility Soluble in DMSO
Storage Please store the product under the recommended conditions in the Certificate of Analysis.

TAKE YOUR NEXT STEPS

Get Started With Our Industry Experience And Client-Centric Focus!

Talk to Us

Copyright © 2024 BOC Sciences. All rights reserved.